Lower levels of tumor-infiltrating macrophages, including CD68+ (~30%), F4/80+ (~50%), and CD11c+ macrophages (~50%), were identified in FUCA1-downregulated glioma tissues, and CCL2/CCL5 neutralizing Abs blocked this effect. The gene discussed is CCL2; the disease is neoplasm.